Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept: Diclofenac as a KMO Inhibitor in Individuals With Alcohol Use Disorder

NCT06029296 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT06029296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06029296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept: Diclofenac as a KMO Inhibitor in Individuals With Alcohol Use Disorder
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 31, 2024
Completion date
August 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder